MX2021013796A - Microparticulas secas. - Google Patents

Microparticulas secas.

Info

Publication number
MX2021013796A
MX2021013796A MX2021013796A MX2021013796A MX2021013796A MX 2021013796 A MX2021013796 A MX 2021013796A MX 2021013796 A MX2021013796 A MX 2021013796A MX 2021013796 A MX2021013796 A MX 2021013796A MX 2021013796 A MX2021013796 A MX 2021013796A
Authority
MX
Mexico
Prior art keywords
dry microparticles
pharmaceutical compositions
microparticles
dry
slow
Prior art date
Application number
MX2021013796A
Other languages
English (en)
Inventor
Sarah Marquette
Audrey Françoise Arrighi
Jonathan Eleuthère Maurice Goole
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Publication of MX2021013796A publication Critical patent/MX2021013796A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se dirige a composiciones farmacéuticas, y, en particular, a composiciones farmacéuticas de liberación lenta que comprenden microesferas poliméricas cargadas con moléculas de anticuerpos, en la forma de micropartículas secas. Las micropartículas secas, y composiciones farmacéuticas que comprenden dichas micropartículas secas, son estables durante la preparación y durante el almacenamiento y demuestran interesantes características de liberación lenta. Además, la invención se refiere a métodos para preparar dichas micropartículas secas.
MX2021013796A 2019-05-15 2020-05-13 Microparticulas secas. MX2021013796A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1906835.2A GB201906835D0 (en) 2019-05-15 2019-05-15 Dry microparticles
PCT/EP2020/063326 WO2020229536A1 (en) 2019-05-15 2020-05-13 Dry microparticles

Publications (1)

Publication Number Publication Date
MX2021013796A true MX2021013796A (es) 2021-12-10

Family

ID=67384654

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021013796A MX2021013796A (es) 2019-05-15 2020-05-13 Microparticulas secas.

Country Status (13)

Country Link
US (1) US20220211627A1 (es)
EP (1) EP3968958A1 (es)
JP (1) JP2022533038A (es)
KR (1) KR20220008853A (es)
CN (1) CN113811292A (es)
AU (1) AU2020275908A1 (es)
BR (1) BR112021019104A2 (es)
CA (1) CA3135455A1 (es)
GB (1) GB201906835D0 (es)
IL (1) IL287984A (es)
MX (1) MX2021013796A (es)
SG (1) SG11202110933YA (es)
WO (1) WO2020229536A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022111547A1 (en) * 2020-11-24 2022-06-02 The University Of Hong Kong Inhaled powder formulations for respiratory delivery of antibodies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5997856A (en) 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
WO1999061062A1 (en) * 1998-05-29 1999-12-02 Massachusetts Institute Of Technology Cyclodextrin complexes
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
EP1980853A1 (en) * 2007-04-11 2008-10-15 Alfresa Pharma Corporation Method of preventing precipitation of a reactive substance-bound microparticle, and reagent containing the micro particle
EP2482804A1 (en) * 2009-10-01 2012-08-08 Evonik Degussa Corporation Microparticle compositions and methods for treating age-related macular degeneration
KR20150128857A (ko) * 2013-03-14 2015-11-18 알러간, 인코포레이티드 지속된-방출 전달의 조성물 및 제조 공정 동안 단백질을 안정화시키는 방법
GB201411320D0 (en) 2014-06-25 2014-08-06 Ucb Biopharma Sprl Antibody construct
CN108938600B (zh) * 2018-07-11 2021-10-08 南京锐利施生物技术有限公司 玻璃体内注射的对抗体药物双重保护的微球及其制备方法

Also Published As

Publication number Publication date
CA3135455A1 (en) 2020-11-19
IL287984A (en) 2022-01-01
CN113811292A (zh) 2021-12-17
WO2020229536A1 (en) 2020-11-19
EP3968958A1 (en) 2022-03-23
BR112021019104A2 (pt) 2021-11-30
US20220211627A1 (en) 2022-07-07
SG11202110933YA (en) 2021-10-28
JP2022533038A (ja) 2022-07-21
AU2020275908A1 (en) 2021-11-04
KR20220008853A (ko) 2022-01-21
GB201906835D0 (en) 2019-06-26

Similar Documents

Publication Publication Date Title
NZ739471A (en) Fertilizer composition and methods of making and using same
AU2018253545A1 (en) Microcrystalline diketopiperazine compositions and methods
WO2016184576A3 (en) Dry powder composition comprising long-chain rna
ZA202304376B (en) Compositions and methods of manufacturing protein microparticles
MX2015001958A (es) Composiciones mejoradas de particulas substancialmente esfericas.
CO6660512A2 (es) Proceso para fabricar composiciones hemostáticas secas y estables
EP4043541C0 (en) MECHANISM OF URIC ACID/SOLID ACID INTERACTION UNDER STORAGE CONDITIONS AND MANUFACTURING METHODS FOR STORAGE-STABLE SOLID COMPOSITIONS CONTAINING UREA AND ACID
GB2535117A (en) A ready to use biodegradable and biocompatable device and a method of preparation thereof
CO6720961A2 (es) Imidazopiridazinas sustituidas
EP4233843A3 (en) Antibody compositions
WO2019048715A3 (en) COMPOSITIONS CONTAINING A BIOMASS COMPOSITION CONTAINING ACTIVATED PECTIN, AND METHODS FOR PREPARING SUCH COMPOSITIONS
EA201791749A1 (ru) Инкапсуляция высокоэффективных активных агентов
MX2021013796A (es) Microparticulas secas.
BR112018067636A8 (pt) Método de produzir uma partícula de fertilizante sólida e composição fertilizante
MX359554B (es) Microesferas cristalinas y proceso para fabricacion de las mismas.
MX2010004962A (es) Mezclas homogeneas y estables en almacenamiento de diferentes particulas de granulos de agentes activos protectores de plantas.
WO2011056775A3 (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
MX359713B (es) Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.
MX2019010228A (es) Composición para liberación controlada de sustancias fisiológicamente activas y proceso para su preparación.
EA201790883A1 (ru) Толерогенные дендритные клетки, способы их получения и их применения
WO2018105941A3 (ko) 탈모방지 또는 발모촉진용 주사용 조성물
GB2514741A (en) Composition for use as a paint binder
WO2014203137A3 (en) Pharmaceutical compositions of tamsulosin or salts thereof
EA201401200A1 (ru) Новая композиция альфентанила для лечения острой боли
RU2013154972A (ru) Способ изготовления порошков для ингаляции